n-(hydroxyethyl)ethylenediaminetriacetic acid and Inflammation

n-(hydroxyethyl)ethylenediaminetriacetic acid has been researched along with Inflammation in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baracat, MM; Casagrande, R; da França, LG; Fattori, V; Georgetti, SR; Mizokami, SS; Pavanelli, WR; Silva, JJ; Staurengo-Ferrari, L; Verri, WA; Zanichelli, PG	1

Other Studies

1 other study(ies) available for n-(hydroxyethyl)ethylenediaminetriacetic acid and Inflammation

Article	Year
The ruthenium nitric oxide donor, [Ru(HEDTA)NO], inhibits acute nociception in mice by modulating oxidative stress, cytokine production and activating the cGMP/PKG/ATP-sensitive potassium channel signaling pathway. Naunyn-Schmiedeberg's archives of pharmacology, 2014, Volume: 387, Issue:11 Topics: Animals; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Edetic Acid; Hyperalgesia; Inflammation; KATP Channels; Male; Mice; Nitric Oxide; Nitric Oxide Donors; Nociception; Oxidative Stress; Ruthenium Compounds; Signal Transduction	2014

Article

Year

The ruthenium nitric oxide donor, [Ru(HEDTA)NO], inhibits acute nociception in mice by modulating oxidative stress, cytokine production and activating the cGMP/PKG/ATP-sensitive potassium channel signaling pathway.

Naunyn-Schmiedeberg's archives of pharmacology, 2014, Volume: 387, Issue:11

Topics: Animals; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Edetic Acid; Hyperalgesia; Inflammation; KATP Channels; Male; Mice; Nitric Oxide; Nitric Oxide Donors; Nociception; Oxidative Stress; Ruthenium Compounds; Signal Transduction

2014